InsiderTrades.com logo

TLPH Insider Trading

Insider Ownership Percentage: 3.20%
Insider Buying (Last 12 Months): $12,941.64
Insider Selling (Last 12 Months): $0.00

Talphera Insider Trading History Chart

This chart shows the insider buying and selling history at Talphera by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Talphera Share Price & Price History

Current Price: $0.48
Price Change: ▲ Price Increase of +0.02 (4.34%)
As of 04/17/2025 04:58 PM ET

This chart shows the closing price history over time for TLPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Talphera Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/5/2024Vincent J AngottiCEOBuy5,000$0.64$3,200.00208,066View SEC Filing Icon  
11/27/2024Vincent J AngottiCEOBuy5,000$0.73$3,650.00203,066View SEC Filing Icon  
6/14/2024Vincent J AngottiCEOBuy1,304$1.08$1,408.32180,806View SEC Filing Icon  
6/13/2024Shakil AslamInsiderBuy695$0.98$681.1032,695View SEC Filing Icon  
6/12/2024Vincent J AngottiCEOBuy4,126$0.97$4,002.22174,932View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Talphera (NASDAQ:TLPH)

37.67% of Talphera stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TLPH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Talphera Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/14/2025Rosalind Advisors Inc.613,939$0.32M0.2%-19.1%3.605%Search for SEC Filing on Google Icon
2/11/2025Rosalind Advisors Inc.613,939$0.32M0.2%-19.1%3.605%Search for SEC Filing on Google Icon
1/29/2025Values First Advisors Inc.96,553$51K0.0%-13.3%0.567%Search for SEC Filing on Google Icon
10/30/2024Rosalind Advisors Inc.758,966$0.65M0.4%N/A4.466%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC1,992,519$1.77M0.1%N/A11.726%Search for SEC Filing on Google Icon
7/31/2024Turtle Creek Wealth Advisors LLC71,500$64K0.0%N/A0.421%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Talphera logo
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
Read More on Talphera

Today's Range

Now: $0.48
Low: $0.47
High: $0.50

50 Day Range

MA: $0.56
Low: $0.46
High: $0.65

52 Week Range

Now: $0.48
Low: $0.45
High: $1.27

Volume

8,233 shs

Average Volume

75,959 shs

Market Capitalization

$8.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.19

Who are the company insiders with the largest holdings of Talphera?

Talphera's top insider investors include:
  1. Vincent J Angotti (CEO)
  2. Shakil Aslam (Insider)
Learn More about top insider investors at Talphera.